ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02811679
Brief Title: A Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma

First Submitted : June 21, 2016
First Submitted that Met QC Criteria : June 22, 2016
First Posted : June 23, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 16, 2018
Last Update Posted : August 17, 2018